Gum Arabic as Antioxidant and Anti-inflammatory in Hemodialysis Patients
NCT03214692 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2017-07-11
Summary
Oxidative processes increased in patients with renal failure and especially patients with end stage renal failure on dialysis. Oxidative stress plays a role in renal damage and also on cardiovascular disease, atherosclerosis, which can accelerate renal damage. Gum Arabic is claimed to have antioxidant effect and this will decrease the harmful effect of the free radical on patient on hemodialysis. In this study investigators are aiming to see the effect of Gum Arabic on Oxidative Stress and inflammatory markers in patients on regular hemodialysis.
Conditions
- End-Stage Renal Disease
Interventions
- DIETARY_SUPPLEMENT
-
Gum Arabic
Oral intake of GA in powder from30 grams per day
Sponsors & Collaborators
-
Military Hospital Sudan
collaborator UNKNOWN -
University of Khartoum
collaborator OTHER -
Lamis Kaddam
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-31
- Primary Completion
- 2017-10-31
- Completion
- 2017-10-31
Countries
- Sudan
Study Locations
More Related Trials
-
Efficacy of Intravenous Iron Administration in Hemodialysis Patients
NCT00298441 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of N-acetylcysteine on Muscle Fatigue in Hemodialysis
NCT00440869 ·Status: COMPLETED ·Phase: PHASE1
-
Relevance of Flavanols for Cardiovascular Function in End-Stage Renal Disease
NCT00835887 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients
NCT00247507 ·Status: UNKNOWN ·Phase: PHASE4
-
Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Stage 3
NCT05264584 ·Status: COMPLETED ·Phase: NA
-
Effect Insulin Pump Therapy to Patients With Diabetic Nephropathy
NCT03174821 ·Status: COMPLETED ·Phase: NA
-
Evaluation of The Effect of Rutin and Vitamin C on the Oxidative Stress in Hemodialysis Patients
NCT04955145 ·Status: UNKNOWN ·Phase: PHASE3
-
Molecular Effects of Vitamin B3 (Niacinamide) in Acute Kidney Injury
NCT02701127 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Curcuminoids and Contrast-induced Acute Kidney Injury
NCT04890704 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease
NCT00808795 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Effect of N-acetyl Cysteine on the Renal Graft Function Biomarkers (IL18, NGAL)
NCT01403506 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Carnitine on Uremic Cardiomyopathy
NCT02322697 ·Status: COMPLETED ·Phase: NA
-
Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes
NCT01978405 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of N-Acetylcysteine on Residual Renal Function in Chronic Hemodialysis Patients
NCT00507052 ·Status: UNKNOWN ·Phase: NA
-
Berberine Prevent Contrast-induced Nephropathy in Patients With Diabetes
NCT02808351 ·Status: COMPLETED ·Phase: PHASE4
-
Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Risk of Acute Kidney Injury in Patients With Heart Failure
NCT02642081 ·Status: UNKNOWN
-
Efficacy of Vitamin E in Preventing Contrast-Induced Acute Kidney Injury Following Coronary Angiography
NCT02070679 ·Status: COMPLETED ·Phase: PHASE3
-
Protective Effects of Oral L-Arginine CI-AKI
NCT02455960 ·Status: UNKNOWN ·Phase: PHASE4
-
N-acetyl Cysteine: the Effectiveness and Safety in a Cohort of Pediatric Patients With Chronic Kidney Disease
NCT04916080 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Homocysteine and Asymmetric Dimethylarginine on Cardiovascular Events in Hemodialysis Patients
NCT00161369 ·Status: COMPLETED
-
Hemofiltration for Contrast-Induced Nephropathy
NCT00158080 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Dexmedetomidine on Kidney Function in EVAR
NCT04766047 ·Status: UNKNOWN ·Phase: NA
-
Telmisartan and Renal Perfusion in Patients With Metabolic Syndrome
NCT00452192 ·Status: COMPLETED ·Phase: PHASE3
-
The Correlation Between Oxidative Stress and Indinated Contrast-Media Nephrotoxicity
NCT00632892 ·Status: COMPLETED
-
Efficacy of Dexmedetomidine in Preventing Contrast Induced Nephropathy
NCT02137863 ·Status: COMPLETED ·Phase: PHASE4